Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

FDA establishes advisory committee for genetic metabolic disease treatments

The committee will evaluate the potential benefits and risks of new therapies for diagnosis, prevention and treatment

EU flag

CHMP recommends gene therapy for beta thalassemia and sickle cell disease

If approved, Casgevy will be the only genetic therapy in the EU to treat these conditions

- PMLiVE

EC, HMA and EMA publish first version of Union list of critical medicines

The established list aims to prevent potential future shortages of critical medicines in the EU

- PMLiVE

Harnessing the power of PR to boost marketing communications

By Gurjit Chahal

- PMLiVE

Astellas’ menopause drug granted EC approval to treat vasomotor symptoms

More than half of women aged 40 to 64 years experience symptoms such as hot flashes

- PMLiVE

Physical activity could reduce breast cancer risk in women before menopause

The disease is responsible for around 47,000 new cases in the UK every year

- PMLiVE

Quality not quantity: why omnichannel matters for medical communications and how to deliver it in practice

By Katy Compton-Bishop and Gareth Morrell

A black background with coloured shapes in the foreground and the title: Using generative AI in healthcare comms - our promise to our clients

Using generative AI in healthcare comms – our promise to our clients

It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...

Cuttsy + Cuttsy

EU flag

EC approves Blueprint’s Ayvakyt as first treatment for rare haematological disorder

The therapy targets the primary underlying cause of indolent systemic mastocytosis

- PMLiVE

Bristol Myers Squibb’s Sotyktu accepted by SMC for plaque psoriasis

More than 133,520 people in Scotland are affected by the inflammatory condition

- PMLiVE

Integrating shared decision-making in patient engagement plans

By Abi Bowden

- PMLiVE

Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward

When it comes to women’s health, “we are a bit behind — almost where oncology was 20 years ago and neuroscience was about 10 years ago,” says Sandra Milligan, Head...

Medscape Education

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links